Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 14 pseudogene 3 is a genomically encoded DNA sequence that is homologous to the functional septin 14 gene but has acquired disabling mutations that prevent the synthesis of a functional protein. Like other pseudogenes, it may be transcribed but does not produce a functional product. Most pseudogenes, including this one, are not currently considered therapeutic targets, receptors, or enzymes, but can occasionally affect the regulation of their parental gene or act as RNA decoys. There is no known disease association, function, or interacting drugs for SEPTIN14P3, and its primary relevance is as a marker of genomic evolution or as a confounding factor in genetic analyses rather than as a meaningful biological target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 14 pseudogene 3 (SEPTIN14P3).